New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma.
Cancer Chemother Pharmacol
; 78(2): 419-26, 2016 Aug.
Article
in En
| MEDLINE
| ID: mdl-27371224
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Acute Kidney Injury
/
Indoles
/
Melanoma
/
Antineoplastic Agents
Type of study:
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2016
Document type:
Article
Affiliation country:
Francia